BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/12/2023 8:10:41 AM | Browse: 565 | Download: 1358
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 82027
Country China
Received
2022-12-04 14:34
Peer-Review Started
2022-12-04 14:35
First Decision by Editorial Office Director
2022-12-26 03:18
Return for Revision
2022-12-26 03:18
Revised
2023-01-09 08:46
Publication Fee Transferred
Editorial Processing by Scientific Editor
2023-03-08 03:04
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2023-03-08 18:07
Articles in Press
2023-03-08 18:07
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-04-06 04:39
Publish the Manuscript Online
2023-04-12 08:10
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
Manuscript Source Invited Manuscript
All Author List Xiao-Chen Feng, Fu-Chen Liu, Wu-Yu Chen, Jin Du and Hui Liu
ORCID
Author(s) ORCID Number
Hui Liu http://orcid.org/0000-0003-4599-5702
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81970453
National Natural Science Foundation of China 82270634
Shanghai Science and Technology Innovation Action Plan Project 20XD1405100
Corresponding Author Hui Liu, MD, PhD, Chief Doctor, Professor, The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, No. 225 Changhai Road, Shanghai 200082, China. liuhuigg@hotmail.com
Key Words Hepatocellular carcinoma; Lipid metabolism; Targeted therapy; Immunotherapy; Drug resistance; Therapeutic efficacy
Core Tip This review systematically summarizes the aberrant changes of lipid metabolism in hepatocellular carcinoma (HCC), and for the first time expounds the impact of lipid metabolism on HCC targeted therapy and immunotherapy. It vividly displayed the changes of lipid metabolism in HCC and the targets of some reagents by drawing figures, and summarized the impact of lipid metabolism related reagents on HCC targeted therapy and immunotherapy through table.
Publish Date 2023-04-12 08:10
Citation Feng XC, Liu FC, Chen WY, Du J, Liu H. Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy. World J Gastrointest Oncol 2023; 15(4): 617-631
URL https://www.wjgnet.com/1948-5204/full/v15/i4/617.htm
DOI https://dx.doi.org/10.4251/wjgo.v15.i4.617
Full Article (PDF) WJGO-15-617.pdf
Full Article (Word) WJGO-15-617.docx